CClinicalTrials.gg
CompletedNCT07740902Updated Aug 3, 2026

CHANGES IN SLEEP QUALITY AND BODY COMPOSITION FOLLOWING A MULTIMODAL LIFESTYLE INTERVENTION IN OLDER WOMEN

An interventional study of Multimodal Lifestyle Intervention in Obesity, Overweight (BMI > 25) and Sleep Quality, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Jan 2024, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
60 Years and older
Sex
Female
01

Study summary

This single-arm pilot study evaluated changes in sleep quality, body composition, biochemical parameters, physical activity, and psychological well-being following a 12-week multimodal lifestyle intervention in overweight and obese women aged 60 years and older. The intervention included individualized nutrition counseling, regular psychological support, and encouragement to walk for at least 150 minutes per week. Participants were assessed at baseline and at the end of week 12. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index. Secondary outcomes included anthropometric measurements, biochemical parameters, physical activity level, and psychological well-being.

Read the detailed description

This study was designed as a single-arm, pre-post pilot study to evaluate the preliminary effects of a 12-week multimodal lifestyle intervention on sleep quality, body composition, biochemical parameters, physical activity, and psychological well-being in overweight and obese women aged 60 years and older.

The study was conducted at a Healthy Living Center in Karabük, Türkiye. Volunteer women aged 60 years and older who were overweight or obese and had access to healthy diet consultation and psychological support services were enrolled. The intervention consisted of individualized nutrition counseling delivered by a registered dietitian, regular psychological support provided every two weeks, and encouragement to perform walking activity for at least 150 minutes per week. Nutrition counseling was tailored according to individual body composition results, lifestyle, dietary habits, and estimated daily energy requirements. Participants attended weekly face-to-face consultations with the dietitian during the 12-week intervention period.

Participants were assessed at baseline and at week 12. The primary outcome was change in sleep quality, assessed using the Pittsburgh Sleep Quality Index. Secondary outcomes included changes in anthropometric measurements, including body weight, body mass index, muscle mass, and body water ratio; biochemical parameters, including fasting blood glucose, fasting insulin, lipid profile, thyroid-stimulating hormone, aspartate aminotransferase, and alanine aminotransferase; physical activity level assessed using the International Physical Activity Questionnaire-Short Form; and psychological well-being assessed using the Psychological Well-Being Scale in the Elderly.

The study aimed to provide preliminary evidence on whether a combined lifestyle approach involving nutrition counseling, psychological support, and regular walking may be associated with improvements in sleep quality and selected health-related outcomes in older women with overweight or obesity. Because this was a single-arm pilot study without a control group, the findings are intended to inform future controlled studies rather than to establish causal effectiveness.

02

Conditions studied

  • Obesity
  • Overweight (BMI > 25)
  • Sleep Quality
  • Body Composition
  • Older Adults

Keywords

  • Older women
  • Lifestyle intervention
  • Nutrition counseling
  • Sleep quality
  • Body composition
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.

This study's enrollment of 36 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Saglik Bilimleri Universitesi is the lead sponsor of 430 studies on the registry; 137 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women aged 60 years or older
  • Being overweight or obese
  • Having access to nutrition counseling and psychological support services at the Healthy Living Center
  • Willingness to participate in the 12-week lifestyle intervention
  • Provision of informed consent

Exclusion criteria

Exclusion Criteria:

  • Age under 60 years
  • Inability to adhere to the nutrition program
  • Inability to adhere to the walking program
  • Following a specific diet at the time of enrollment
  • Presence of serious chronic kidney, heart, or endocrine disease
  • Presence of severe depressive problems
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Multimodal Lifestyle Intervention Group

    Participants received a 12-week multimodal lifestyle intervention including individualized nutrition counseling, psychological support every two weeks, and recommendations for regular walking activity for at least 150 minutes per week.

    Behavioral: Multimodal Lifestyle Intervention

Interventions

  • BehavioralMultimodal Lifestyle Intervention

    The intervention consisted of individualized nutrition counseling provided by a registered dietitian, psychological support provided every two weeks, and recommendations for regular walking activity for at least 150 minutes per week over a 12-week period.

06

What researchers measure

Primary outcomes

  1. Change in Pittsburgh Sleep Quality Index total score

    Sleep quality was assessed using the Pittsburgh Sleep Quality Index. The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline and week 12

Secondary outcomes

  1. Change in body weight measured in kilograms

    Body weight was measured in kilograms at baseline and week 12. The change in body weight over the 12-week intervention period was evaluated.

    Time frame: Baseline and week 12

  2. Change in body mass index (BMI) (kg/m²)

    Body mass index was calculated as weight in kilograms divided by height in meters squared. The change in BMI from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  3. Change in muscle mass measured by bioelectrical impedance analysis (kg)

    Muscle mass was assessed using bioelectrical impedance analysis and reported in kilograms. The change in muscle mass from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  4. Change in body water percentage measured by bioelectrical impedance analysis

    Body water percentage was assessed using bioelectrical impedance analysis. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  5. Change in fasting blood glucose concentration (mg/dL)

    Fasting blood glucose was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  6. Change in fasting serum insulin concentration (mIU/mL)

    Fasting insulin was measured in mIU/mL. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  7. Change in total cholesterol concentration(mg/dL)

    Total cholesterol was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  8. Change in LDL cholesterol concentration (mg/dL)

    LDL cholesterol was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  9. Change in HDL cholesterol concentration (mg/dL)

    HDL cholesterol was measured in mg/dL. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  10. Change in serum triglyceride concentration (mg/dL)

    Triglycerides were measured in mg/dL. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  11. Change in thyroid-stimulating hormone concentration (mIU/L)

    Thyroid-stimulating hormone was measured in mIU/L. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  12. Change in aspartate aminotransferase activity (IU/L)

    Aspartate aminotransferase was measured in IU/L. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  13. Change in alanine aminotransferase activity (U/L)

    Alanine aminotransferase was measured in U/L. The change from baseline to week 12 was evaluated.

    Time frame: Baseline and week 12

  14. Change in Psychological Well-Being Scale in the Elderly total score

    Psychological well-being was assessed using the Psychological Well-Being Scale in the Elderly. Higher scores indicate greater psychological well-being.

    Time frame: Baseline and week 12

  15. Change in International Physical Activity Questionnaire-Short Form total score

    Physical activity was assessed using the International Physical Activity Questionnaire-Short Form and reported as MET-minutes/week.

    Time frame: Baseline and week 12

07

Study locations

1 site
  • Healthy Living Center, Karabük
    Karabük, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to participant privacy and ethical restrictions.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07740902
Lead sponsor
Saglik Bilimleri Universitesi
Responsible party
Pınar Göbel (Assoc. Prof. Dr., Saglik Bilimleri Universitesi) — Principal investigator
First posted
Aug 3, 2026
Start date
Jan 15, 2024
Primary completion
Jun 30, 2024
Completion
Jul 15, 2024
Last update
Aug 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion